IP Library Granted Patent US 12,427,194
Granted Patent B2
US 12,427,194 · App. 17/202,007 · Granted Sep 30, 2025

Composition and methods for treating acute diarrhea and enteric

Inventor: Thomas A. Schultz (Oviedo, FL)
Assignee: MAMMAL LABS INC.
A61K39/42A23K20/147A23K50/40A61K35/20A61K35/57A61P1/12A61P31/04A61P31/20A61K2039/552
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,427,194
App. No.
17/202,007
Granted
Sep 30, 2025
Kind
B2
Abstract

The composition may be used therapeutically or prophylactically and is directed toward a cluster of diarrhea-causing pathogens which cause illness or death in animals, including dogs and cats. It is prepared from a powdered egg preparation and powdered protein matrix, such as bovine colostrum. The eggs are collected from hens which have been immunized with the relevant pathogens or toxins. When the matrix includes colostrum, the powdered colostrum is derived from non-hyperimmune cattle. The vaccination strategy includes the use of antibody cross-reactivity between toxins or pathogens which cause diarrhea. For some diseases, including canine parvo, the clinical improvement using this therapeutic exceeds the standard of care. Instead of a pharmaceutical product, this composition is an orally administered food product with the same safety profile as eggs and milk.

Claims (30)

1. A composition for treatment or prevention of diarrhea or enteric infection in animals, the composition comprising:

a. a mixture of IgY antibodies specific for a plurality of antigens obtained from a plurality of organisms, wherein the organisms cause diarrhea in animals, and wherein a mercury content in the mixture is less than 0.001 ppm; and

b. a protective matrix comprising protein, wherein the protein is derived from a non-hyperimmune animal source and comprises at least 20 percent of the composition by weight.

2. The composition of claim 1 , wherein the mixture of IgY antibodies is obtained from one or more eggs laid by one or more birds, wherein each of the one or more birds have been vaccinated with the plurality of antigens.

3. The composition of claim 1 , wherein each of the plurality of organisms is independently selected from the group consisting of: a species of the genus Clostridium , a species of the genus Yersinia , a species of the genus Brachyspira , a species of the genus Campylobacter, Escherichia coli, Helicobacter spp., a species of the genus Salmonella , a species of the genus Leptospira, Providencia alcalifaciens, Mycobacterium paratuberculosis, Lawsonia intracellularis , bovine viral diarrhea virus, infectious bovine rhinotracheitis virus, coronavirus, rotavirus, parvovirus, paramyxovirus, hepatitis virus, feline leukemia virus, feline immunodeficiency virus, feline panleukopenia virus, astrovirus, transmissible gastroenteritis, Giardia, Coccidia, Entamoeba histolytica, Cryptosporidium , roundworm, whipworm, spirochetes, yeasts, or molds.

4. The composition of claim 1 wherein each of the plurality of organisms is independently selected from group consisting of: rotavirus, coronavirus, Escherichia coli, Clostridium perfringens, Campylobacter fetus, Campylobacter jejuni , or parvovirus.

5. The composition of claim 1 , wherein the animal is a member of the Canidae or Felidae families.

6. The composition of claim 1 , wherein the non-hyperimmune animal is a ruminant.

7. The composition of claim 1 , wherein the animal is bovine.

8. A method comprising:

a. providing a mixture of IgY antibodies specific for a plurality of antigens obtained from a plurality of organisms, wherein the organisms cause diarrhea in animals, wherein a mercury content in the mixture is less than 0.001 ppm and wherein one of the organisms is parvovirus;

b. combining the mixture of IgY antibodies with a protective matrix comprising protein, wherein the combining results in a composition, and wherein the protein is derived from a non-hyperimmune animal source and comprises at least 20 percent of the composition by weight; and

c. treating a sick animal using the composition, the treatment comprising:

administering the composition to a sick animal infected with at least one of the organisms;

monitoring one or more symptoms of the sickness; and

establishing an efficacy of the composition based on an absence of the symptoms and an eradication of the sickness in the animal based on testing.

9. The method of claim 8 , wherein the mixture of IgY antibodies is obtained from one or more eggs laid by one or more birds, wherein each of the one or more birds have been vaccinated with the plurality of antigens.

10. The method of claim 8 , wherein each of the plurality of organisms is independently selected from the group consisting of: a species of the genus Clostridium , a species of the genus Yersinia , a species of the genus Brachyspira , a species of the genus Campylobacter, Escherichia coli, Helicobacter spp., a species of the genus Salmonella , a species of the genus Leptospira, Providencia alcalifaciens, Mycobacterium paratuberculosis, Lawsonia intracellularis , bovine viral diarrhea virus, infectious bovine rhinotracheitis virus, coronavirus, rotavirus, parvovirus, paramyxovirus, hepatitis virus, feline leukemia virus, feline immunodeficiency virus, feline panleukopenia virus, astrovirus, transmissible gastroenteritis, Giardia, Coccidia, Entamoeba histolytica, Cryptosporidium , roundworm, whipworm, spirochetes, yeasts, or molds.

11. The method of claim 8 wherein each of the plurality of organisms is independently selected from group consisting of: rotavirus, coronavirus, Escherichia coli, Clostridium perfringens, Campylobacter fetus, Campylobacter jejuni , or parvovirus.

12. The method of claim 8 , wherein the animal is a member of the Canidae or Felidae families.

13. The method of claim 8 , wherein the non-hyperimmune animal is a ruminant.

14. The method of claim 8 , wherein the animal is bovine.

15. The composition of claim 1 , wherein the composition is administered as a vaccine to a healthy animal to provide immunity against illness caused by at least one of the organisms or as a treatment to a sick animal infected with at least one of the organisms.

16. The method of claim 8 , further comprising administering the composition as a vaccine to a healthy animal to provide immunity against illness caused by at least one of the organisms.

17. A composition comprising:

a. a mixture of IgY antibodies specific for a plurality of antigens obtained from a plurality of organisms, wherein the organisms cause diarrhea in animals, and wherein a mercury content in the mixture is less than 0.001 ppm; and

b. a protective matrix comprising protein, wherein the protein is derived from a non-hyperimmune animal source and comprises at least 20 percent of the composition by weight, wherein the composition is administered to a healthy animal on a daily basis as a prophylactic against illness caused by at least one of the organisms.

18. A method for preparing a treatment or preventative composition for diarrhea or enteric infection in animals, the method comprising:

a. providing a mixture of IgY antibodies specific for a plurality of antigens obtained from a plurality of organisms, wherein the organisms cause diarrhea in animals, wherein one of the organisms is parvovirus, and wherein a mercury content in the mixture is less than 0.001 ppm; and

b. combining the mixture of IgY antibodies with a protective matrix comprising protein, wherein the protein is derived from a non-hyperimmune animal source and comprises at least 20 percent of the composition by weight.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 27, 2025
From: STEVENS LAW GROUP
To: MAMMAL LABS INC.
Reel/Frame 070655/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2024
From: SINGER, KEVIN
To: STEVENS LAW GROUP
Reel/Frame 067467/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2023
From: ANUBIS BIO CORP.
To: SINGER, KEVIN
Reel/Frame 064682/0936 →
COURT ORDER Recorded Aug 16, 2023
From: ANUBIS BIO CORP.
To: SINGER, KEVIN
Reel/Frame 064612/0583 →
LIEN Recorded May 22, 2023
From: ANUBIS BIO CORP.
To: STEVENS LAW GROUP
Reel/Frame 063720/0825 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2021
From: SCHULTZ, THOMAS A.
To: ANUBIS BIO CORPORATION
Reel/Frame 055596/0466 →
Continuity (3)
Division 16591025 · Oct 2, 2019
Provisional Application 62740769 · Oct 3, 2018
Related Publication 20210196825A1 · Jul 1, 2021
References Cited (3)
WO WO2012071346A1 · 2012 [cited by examiner]
WO WO2015004181A1 · 2015 [cited by examiner]
Ian Battersby and Andrea Harvey, Differential diagnosis and treatment of acute diarrhoea in the dog and cat, in Practice, Sep. 2006, pp. 480-488. [cited by applicant]